Breaking

•3-day investigation leads to arrest in vape shop break-in - Sandhills Sentinel •Novaspira Biotherapeutics Late-Breaking Oral Presentation of Phase 1 Data for a Novel GPC3x4-1BB Bispecific at SITC 2026 - EIN Presswire •New York Vet Show 2026: DEA fines, AI, fresh diets, and regenerative medicine on the schedule - DVM360 •GW Public Health Experts Call for Greater Investment in Preventing Zoonotic Diseases Amid Climate Change and Global Health Funding Shifts | Newswise - Newswise •Experts convene for 1980 federal climate change conference - History.com •Chelsea’s fine finishing has them flying high – but how long can it last? - The Guardian •Anthony Edwards undergoes arthroscopic knee debridement - Bring Me the Sports •AJ Dybantsa Scores 19 Points in NBA Debut - Yahoo Sports •Why Five Star Recruit Picked Duke Basketball Program - Yahoo Sports •Clayton Silva Set to Leave Olympiacos - Yahoo Sports •Multiple Sports Owners Were Major Backers of Elizabeth Holmes - Front Office Sports •5 summer sports that dominated betting in 2026 - Centre Daily Times •CAMBUS Shuttles to Carver-Hawkeye Arena for Winter Sports - The University of Iowa •Tech's 20 Beaten-Down Stocks Have Sunk up to 65%: Which ETFs Could Ride an AI Rebound? - TradingView •Free Funhouse at Pacific Park Santa Monica This Halloween - Santa Monica Daily Press •Georgia-Pacific Invests Approximately $150 Million in Palatka, Florida, to Modernize Angel Soft® Bath Tissue Production - Georgia-Pacific •Oil falls as diplomacy hopes outweigh Middle East escalation fears - Euronext Markets: Real-time Stock Market Data | live •South Africa’s Sexual Reproductive Justice Strategy: From Rights to Reality - Partnership for Maternal, Newborn and Child Health •EU pressure on Antigua's 'golden passport' trade threatens budget cushion - Reuters •Putin says Russia is ‘ready for war’ with Europe in chilling threat - The Independent •3-day investigation leads to arrest in vape shop break-in - Sandhills Sentinel •Novaspira Biotherapeutics Late-Breaking Oral Presentation of Phase 1 Data for a Novel GPC3x4-1BB Bispecific at SITC 2026 - EIN Presswire •New York Vet Show 2026: DEA fines, AI, fresh diets, and regenerative medicine on the schedule - DVM360 •GW Public Health Experts Call for Greater Investment in Preventing Zoonotic Diseases Amid Climate Change and Global Health Funding Shifts | Newswise - Newswise •Experts convene for 1980 federal climate change conference - History.com •Chelsea’s fine finishing has them flying high – but how long can it last? - The Guardian •Anthony Edwards undergoes arthroscopic knee debridement - Bring Me the Sports •AJ Dybantsa Scores 19 Points in NBA Debut - Yahoo Sports •Why Five Star Recruit Picked Duke Basketball Program - Yahoo Sports •Clayton Silva Set to Leave Olympiacos - Yahoo Sports •Multiple Sports Owners Were Major Backers of Elizabeth Holmes - Front Office Sports •5 summer sports that dominated betting in 2026 - Centre Daily Times •CAMBUS Shuttles to Carver-Hawkeye Arena for Winter Sports - The University of Iowa •Tech's 20 Beaten-Down Stocks Have Sunk up to 65%: Which ETFs Could Ride an AI Rebound? - TradingView •Free Funhouse at Pacific Park Santa Monica This Halloween - Santa Monica Daily Press •Georgia-Pacific Invests Approximately $150 Million in Palatka, Florida, to Modernize Angel Soft® Bath Tissue Production - Georgia-Pacific •Oil falls as diplomacy hopes outweigh Middle East escalation fears - Euronext Markets: Real-time Stock Market Data | live •South Africa’s Sexual Reproductive Justice Strategy: From Rights to Reality - Partnership for Maternal, Newborn and Child Health •EU pressure on Antigua's 'golden passport' trade threatens budget cushion - Reuters •Putin says Russia is ‘ready for war’ with Europe in chilling threat - The Independent

TheNewsPulse.pro

One World. Every Story. For a Smarter Tomorrow.

Home/breaking news/government/international relations

breaking_news

Novaspira Biotherapeutics Late-Breaking Oral Presentation of Phase 1 Data for a Novel GPC3x4-1BB Bispecific at SITC 2026 - EIN Presswire

Confidence80·developingImportance85NP-EVT-20261029-B714EE4

Novaspira Biotherapeutics Late-Breaking Oral Presentation of Phase 1 Data for a Novel GPC3x4-1BB Bispecific at SITC 2026    EIN Presswire

Read the original at the primary source

Novaspira Biotherapeutics Late-Breaking Oral Presentation of Phase 1 Data for a Novel GPC3x4-1BB Bispecific at SITC 2026 - EIN Presswire

10/29/2026, 5:59:00 PM

Additional coverage (1)

Novaspira Biotherapeutics Late-Breaking Oral Presentation of Phase 1 Data for a Novel GPC3x4-1BB Bispecific at SITC 2026 - The Des Moines Register

Also on the network: airlinesairports · farmerspulse · foodpulse · indias · naturepulse · travelerpulse

Discussion

ChatsPulse · 0 threads

No discussion yet. Sign in and start the first thread —